ИЗУЧЕНИЕ ВЛИЯНИЯ КОНЦЕНТРАЦИИ МОЧЕВОЙ КИСЛОТЫ С ГИПЕРУРИКЕМИЕЙ В СЫВОРОТКЕ КРОВИ И МОЧЕ ПРИ ЭКСПЕРИМЕНТЕ

Article Sidebar

PDF (O'zbekcha)
Published: iyl 11, 2023
Keywords:
vHyperuricemia, serum, arterial hypertension, uric acid, coronary heart disease, pathology, metabolic syndrome, ethylene glycol, allapurinol.

Main Article Content

М.Расулова
Ф.Расулов
У.Болтабоев

Abstract

In recent years, a large number of reports have appeared on the association of elevated serum uric acid levels with the risk of progression of arterial hypertension, ischemic heart disease, and a prognosis in patients with these diseases. At the same time, there is a small amount of work devoted to the clinical and prognostic value of hyperuricemia in chronic heart failure, although this pathology remains one of the unfavorable prognosis in the series of cardiovascular imperfections.


 

Article Details

How to Cite
М.Расулова, Ф.Расулов, & У.Болтабоев. (2023). ИЗУЧЕНИЕ ВЛИЯНИЯ КОНЦЕНТРАЦИИ МОЧЕВОЙ КИСЛОТЫ С ГИПЕРУРИКЕМИЕЙ В СЫВОРОТКЕ КРОВИ И МОЧЕ ПРИ ЭКСПЕРИМЕНТЕ. Scientific Journal of the Fergana State University, (4), 29. Retrieved from https://journal.fdu.uz/index.php/sjfsu/article/view/1684
Issue
No. 4 (2017): Scientific journal of the Fergana State University
Section
Scientific information

References

Вартанян Л.С., Гуревич С.М. «Вопросы медицинской химии». ‒ М., 1982. // Выпуск. ‒ № 28 (5), стр. 23-26.

Leyva F., Anker S., GodslandI. Etal. Uric acid in chronic heart failure; a marker of chronic inflammation, eur.HeartJ. 1998: 19; 11814-1822.

S.Anker, Doehner N., Raucchaus M. Et.al. Uric acid in chronic heart failure; validation and application in metabolic, functional and hemodynamic staging.Circulation, 2003; 107: 1991-1997.